✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹10 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
10.00 Cr
PE
PE
-
Prom Holding
Prom Holding
27.10 %
ROE (%)
ROE (%)
0.44
ROCE (%)
ROCE (%)
6.36
Div Yield (%)
Div Yield (%)
-
Sales
Sales
30.88 Cr
OPM (%)
OPM (%)
-9.80 %
Debt to Equity
Debt to Equity
1.40
About
Cian Healthcare Limited is a pharmaceutical company that specializes in developing, manufactur… Read more
Low
3
52W Range
High
25
  • Cian Healthcare
  • Unjha Formulations
  • Hind Bio Science

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Cian Healthcare Ltd. Business

Cian Healthcare Limited specializes in developing, manufacturing, and commercializing pharmaceutical products across 12 therapeutic segments. They operate under various business models and offer a range of innovative products including those for veterinary use.

Cian Healthcare major competitors are Unjha Formulations, Adline Chem Lab, Colinz Laboratories, Beryl Drugs, Decipher Labs, Hind Bio Science, Ortin Global.
Market Cap of Cian Healthcare is ₹10 Crs.
While the median market cap of its peers are ₹10 Crs.

Cian Healthcare seems to be less financially stable compared to its competitors.
Altman Z score of Cian Healthcare is 0.85 and is ranked 5 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material